Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol TRIP12 contributors: mct - updated : 28-02-2015
HGNC name thyroid hormone receptor interactor 12
HGNC id 12306
Corresponding disease
MRD49 mental retardation, autosomal dominant 49
Location 2q36.3      Physical location : 230.631.929 - 230.786.655
Synonym symbol(s) KIAA0045, H4, MGC138849, MGC138850, TRIP-12, ULF
EC.number 6.3.2.-
DNA
TYPE functioning gene
STRUCTURE 158.20 kb     41 Exon(s)
10 Kb 5' upstream gene genomic sequence study
MAPPING cloned Y linked N status provisional
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
42 - 10035 - 2040 - 2009 19028681
39 - 9082 - 1722 - 2009 19028681
41 - 9892 - 1992 - 2009 19028681
40 - 9861 - 2025 - 2009 19028681
EXPRESSION
Type ubiquitous
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveliver    
 mouthgingiva   
Endocrinethyroid   highly
Lymphoid/Immunelymph node   highly
Nervousbrain   lowly Homo sapiens
 spinal cord    
Reproductivemale systemtestis   
Urinarybladder   highly
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / Hematopoieticbone marrow   
Muscularstriatum  highly Homo sapiens
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • N-terminal region containing armadillo repeats and a WWE domain, both of which are presumed to mediate protein-protein interactions (Park 2009)
  • one HECT-type E3 ubiquitin-protein ligase domain, that possesses a noncovalent ubiquitin-binding site, unique in that the HECT domain can conjugate ubiquitin to noncovalently bound ubiquitin (Park 2009)
  • 7 RCC1 domains
  • an ARM domain (armadillo/CTNNB1-like repeats)
  • HOMOLOGY
    Homologene
    FAMILY HECT family
    CATEGORY regulatory
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,cytosolic
    intracellular,nucleus,nucleoplasm
    basic FUNCTION
  • HECT domain-containing E3 ubiquitin–protein ligase
  • activating the proteolytic activities of the multifunctional proteinase (20s proteasome) of the 26s complex and specifically interacting with the ligand binding domain of the thyroid hormone receptor
  • functions as an E3 enzyme of NAE1 and additionally requires an E4 activity for polyubiquitination of NAE1
  • promotes degradation of NAE1 by catalyzing its ubiquitination, which in turn modulates the neddylation pathway
  • can recognize UFD substrates and catalyze their ubiquitination, through its HECT domain (Park 2009)
  • is potentially involved in global gene expression and plays an important role in embryonic development
  • TRIP12 and UBR5, two HECT domain ubiquitin E3 ligases, control accumulation of RNF168, a rate-limiting component of a pathway that ubiquitylates histones after DNA breakage
  • HUWE1 and TRIP12 function likely in parallel during ubiquitin fusion degradation (UFD)
  • PTF1A/TRIP12 functional interaction may regulate pancreatic epithelial cell homeostasis
  • E3 ubiquitin ligase TRIP12 plays an important role in nervous system development and function
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    ubiquitin fusion degradation (UFD) pathway
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interaction with NAE1 (ubiquitinates NAE1)
  • is a bona fide E3 ligase for CDKN2A, suggesting that TRIP12 is an important target for activating the CDKN2A-TP53 axis in acute myeloid leukaemia (AML) cells
  • TRADD shuttles dynamically from the cytoplasm into the nucleus to modulate the interaction between CDKN2A and its E3 ubiquitin ligase TRIP12, thereby promoting CDKN2A stability and tumour suppression
  • interaction with CUL1 (regulates neddylation of CUL1)
  • recognizes and polyubiquitinates SOX6
  • GNL3 stabilizes CDKN2A by inhibiting the ubiquitin ligase TRIP12
  • TRIP12 is an E3 ubiquitin-protein ligase as a new partner of PTF1A (protein stability of PTF1A is significantly increased upon decreased expression of TRIP12)
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) MRD49
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS
  • homozygous mutation in Trip12 (Trip12(mt/mt)) that disrupts the ubiquitin ligase activity resulted in embryonic lethality in the middle stage of development